METHOD FOR CANCER CELL BIOMARKER IDENTIFICATION, AND AN NMD-IRRELEVANT CANCER CELL BIOMARKER IDENTIFIED BY MEANS OF THE METHOD

摘要

Provided are: a biomarker identification method for cancer cells; a biomarker for cancer cells identified by means of the method; a cancer diagnostic kit comprising the biomarker; a screening method for anticancer agents; and a pharmaceutical composition for preventing or treating cancer, comprising a pharmaceutically effective dose of an antibody or a peptide aptamer that binds specifically to a cancer specific protein. The biomarker identification method for cancer cells of the present invention does not involve examining individual genes one by one in order to test their potential as biomarkers, but rather uses a method involving twice screening genes wherein mutation frequently occurs by means of a bioinformatics technique, and thus the method of the present invention allows a plurality of biomarkers to be identified in a fashion which is very straightforward but nevertheless accurate.